According to foreign media reports, Pfizer recently announced that it will cut 2% of its employees worldwide to streamline its structure, and said that it will achieve this goal by the end of this year and early 2019, mainly by voluntary resignation and early retirement. Both departments and departments may be affected, and layoffs are mainly targeted at non-union employees.

Pfizer spokesperson Sally Beatty told CNBC: "As we prepare for growth, we are also creating a simpler, more efficient organizational structure that will affect some management positions, and we are improving certain benefits to reduce With this effect, the overall labor force will be reduced by 'a few percentage points'."

According to Pfizer's latest financial statements, the company currently employs approximately 90,000 people worldwide, which is calculated to include 1,800 jobs. In fact, this is not the first time Pfizer has cut jobs. On January 7 this year, Pfizer announced that it would stop all new drug developments for Alzheimer's and Parkinson's disease. It is planned to abolish Andord and Cambridge in Massachusetts and Groton in Connecticut. There are about 300 positions in neuroscience research and early development projects, and some of the ongoing research projects in clinical I/II are stopped.

In addition, Pfizer has also adjusted the company's organizational structure this year. Pfizer announced in July that it will restructure its global structure and reorganize into three divisions: a science-based innovative pharmaceuticals business; a mature pharmaceutical business focused on patented branded and generic drugs and having considerable autonomy within Pfizer; and health Drug business. In addition, the consumer health care business that the company has been trying to sell will be divested. The above layoff plan is part of the Pfizer restructuring plan, and these changes are expected to take effect at the beginning of Pfizer's fiscal year 2019.

Earlier this month, Pfizer announced that 56-year-old COO Albert Bourla succeeded Ian Read as CEO, which took effect on January 1, 2019. Read's position will also be changed from the chairman and CEO of the board to the executive chairman of the board of Pfizer. Last week, Bourla announced that it will make personnel changes to the management team on January 1st, and said in a statement, "We are at a critical moment in Pfizer's history."

Read said in a July statement that based on the ongoing demand for current products and subsequent R&D, and the expected expiration of patents after 2020, the new architecture represents a natural evolution of these businesses, and the impact of the loss due to patent protection expiration will Significantly reduced. “As we transition to a period after 2020, we expect higher and more sustained revenue growth, and this new structure will better position each business to achieve its growth potential.”

With regard to specific layoffs and compensation for compensation, Pfizer said it will provide a severance payment equivalent to 12 weeks of basic salary, plus three weeks of work per year, up to 104 weeks. Employees who voluntarily retire early can receive any vested rights, health insurance and other benefits, and the current tax rate can be up to three years. Employees who are 55 years of age and have worked in the company for at least 10 years may be eligible for early retirement. According to the documents, employees will choose the early retirement plan from October 16th to November 2nd, unless their manager asks to stay for a few more months, otherwise they will leave before December 31st.

Pfizer said that the company's management will observe how many employees choose to voluntarily retire and will assess the needs of the company's staff, and then will decide on the issue of “involuntary layoffs.” Involuntary resigned employees will be eligible for the program. Basically the same benefits, which are more generous than their typical layoffs.

It is also known that Pfizer's headquarters is currently located in New York, after the company announced a plan in April to move its headquarters address from 42nd Street to Hudson Park starting in 2022.

Guangzhou Zhongzhinan Supply Chain Co.,Ltd. , https://www.zhongzhinanlighting.com